MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

INVO Fertility, Inc. (IVF)

INVO Fertility, Inc. (IVF)

|||

Cash Flow Overview

Change in Cash
-$1,171,510
Free Cash flow
-$1,121,018
Unit: Dollar
Positive Cash Flow Breakdown
    • Net loss
    • Loss from debt extinguishment
    • Depreciation and amortization
    • Others
Negative Cash Flow Breakdown
    • Remeasurement of note receivable
    • Interest receivable
    • Accounts payable and accrued exp...
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Non-cash compensation for services
0
-
0
45,000
Amortization of discount on notes payable
0
-
1,050,335
1,736
Impairment loss
0
-
0
0
Gain on changes in fair value
-
-
5,172,006
-
Loss on disposition
0
-
0
0
Gain on settlement
0
-
-685,500
840,500
Net loss
-
-
-
-2,644,625
Other current liabilities
0
-
940,000
0
Non-cash stock compensation issued for services
24,260
70,921
140,247
481,430
Fair value of vested stock options
94,311
94,311
84,281
11,918
Provision for credit losses
41,230
-
-
-
(gain) loss from equity method investment
-7,154
22,168
23,282
12,827
Loss from debt extinguishment
-172,621
-
-567,419
-876,165
Remeasurement of note receivable
2,452,032
-
-
-
Gain (loss) on change in fair value of warrant liability
0
3,790,225
943,862
-
Depreciation and amortization
145,573
142,698
136,425
136,741
Accounts receivable
35,220
31,124
4,836
31,945
Interest receivable
139,514
-
-
-
Inventory
4,120
-698
33,491
-20,849
Prepaid expenses and other current assets
-12,935
115,619
-73,807
-80,354
Accounts payable and accrued expenses
-93,945
-394,401
-878,785
245,194
Non-cash stock compensation issued to directors and/or employees
-
-
0
-
Accrued compensation
73,660
64,011
-347,008
-22,737
Reserve on other assets
-
-
0
-
Deferred revenue
63,005
3,596
1,490
-114,443
Gain on lease termination
-
-
0
-
Leasehold liability
23,694
12,242
-573
1,887
Equity investments
-
-
0
-
Accrued interest
20,072
7,386
14,922
-10,734
Loss on disposal of fixed assets
-
-
0
-
Deferred tax liabilities
56,129
-
-163,115
-
Net loss
888,740
-5,539,351
-23,323,054
-
Net cash used in operating activities
-1,101,447
-1,916,575
25,207
-1,776,537
Divesture of naya
0
-
0
0
Proceeds from sale of fixed assets
-
-
0
-
Payments to acquire property, plant, and equipment
19,571
-
11,823
8,062
Cash received in acquisition
17,355
-
0
-
Payment for acquisition
0
210,000
2,695,500
-
Net cash used in investing activities
-2,216
-210,000
-2,707,323
-8,062
Proceeds from notes payable
-
-
0
-
Proceeds from the sale of common stock, net of offering costs
0
-
3,607,705
0
Proceeds from sale of preferred stock
0
-
700,000
1,650,000
Preferred stock redemption
0
-
-
-
Proceeds from warrant exercise, net
0
7,094,845
66,401
19,566
Preferred stock redemption
-
-
0
0
Payment deferred acquisition consideration
0
2,025,000
-
-
Principal payments on notes payable
67,847
116,657
-29,961
78,257
Net cash provided by financing activities
-67,847
4,953,188
4,404,067
1,591,309
Increase in cash and cash equivalents
-
-
1,721,951
-
Increase (decrease) in cash
-1,171,510
2,826,613
1,721,951
-193,290
Cash at beginning of period
4,904,455
2,077,842
355,891
741,396
Cash at end of period
3,732,945
4,904,455
2,077,842
355,891
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Increase (decrease) incash-$1,171,510 (-509.48%↓ Y/Y)Net loss$888,740 (103.92%↑ Y/Y)Loss from debtextinguishment-$172,621 (75.06%↑ Y/Y)Depreciation andamortization$145,573 (-63.98%↓ Y/Y)Fair value of vestedstock options$94,311 (14.27%↑ Y/Y)Accrued compensation$73,660 (-65.97%↓ Y/Y)Deferred revenue$63,005 (-72.90%↓ Y/Y)Deferred tax liabilities$56,129 Provision for creditlosses$41,230 Non-cash stockcompensation issued for...$24,260 (-96.37%↓ Y/Y)Leasehold liability$23,694 (151.88%↑ Y/Y)Accrued interest$20,072 (-82.53%↓ Y/Y)Prepaid expenses andother current assets-$12,935 (-104.71%↓ Y/Y)(gain) loss from equitymethod investment-$7,154 (-48.58%↓ Y/Y)Cash received inacquisition$17,355 Net cash used inoperating activities-$1,101,447 (79.07%↑ Y/Y)Net cash provided byfinancing activities-$67,847 (-101.33%↓ Y/Y)Net cash used ininvesting activities-$2,216 (92.64%↑ Y/Y)Canceled cashflow$1,623,384 Canceled cashflow$17,355 Remeasurement of notereceivable$2,452,032 Principal payments onnotes payable$67,847 (-94.21%↓ Y/Y)Payments to acquireproperty, plant, and...$19,571 (-16.81%↓ Y/Y)Interest receivable$139,514 Accounts payable andaccrued expenses-$93,945 (86.37%↑ Y/Y)Accounts receivable$35,220 (-47.72%↓ Y/Y)Inventory$4,120 (157.60%↑ Y/Y)